MMR on 12 Month
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study on the Withdrawal of Second-generation Tyrosine Kinase Inhibitors After Dose Reduction in Patients With CML (NCT05341050) | xuna | 2022-04-01 |
| Withdrawal or Reduction TKIs in CML-CP (NCT04143087) | Nanfang Hospital, Southern Medical University | 2019-10-23 |
Track MMR on 12 Month automatically
Every clearance here is in the API, with alerts when new ones post.